======= PRDM5 ======= == Gene Information == * **Official Symbol**: PRDM5 * **Official Name**: PR/SET domain 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11107|11107]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQX1|Q9NQX1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRDM5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRDM5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614161|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a transcription factor of the PR-domain protein family. It contains a PR-domain and multiple zinc finger motifs. Transcription factors of the PR-domain family are known to be involved in cell differentiation and tumorigenesis. [provided by RefSeq, Jul 2008]. COMPLETENESS: complete on the 3' end. * **UniProt Summary**: Sequence-specific DNA-binding transcription factor. Represses transcription at least in part by recruitment of the histone methyltransferase EHMT2/G9A and histone deacetylases such as HDAC1. Regulates hematopoiesis-associated protein-coding and microRNA (miRNA) genes. May regulate the expression of proteins involved in extracellular matrix development and maintenance, including fibrillar collagens, such as COL4A1 and COL11A1, connective tissue components, such as HAPLN1, and molecules regulating cell migration and adhesion, including EDIL3 and TGFB2. May caused G2/M arrest and apoptosis in cancer cells. {ECO:0000269|PubMed:15077163, ECO:0000269|PubMed:17636019, ECO:0000269|PubMed:21664999}. No Pfam Domain information is available for this gene. |histone H3-K9 methylation| |histone H3-K9 modification| |repressing transcription factor binding| |histone deacetylation| |protein deacetylation| |methyltransferase activity| |protein deacylation| |macromolecule deacylation| |chromatin DNA binding| |histone lysine methylation| |peptidyl-lysine methylation| |histone methylation| |response to leukemia inhibitory factor| |cellular response to leukemia inhibitory factor| |protein methylation| |protein alkylation| |transcription regulatory region DNA binding| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |macromolecule methylation| |nuclear body| |methylation| |peptidyl-lysine modification| |RNA polymerase II regulatory region sequence-specific DNA binding| |histone modification| |covalent chromatin modification| |sequence-specific DNA binding| |RNA polymerase II proximal promoter sequence-specific DNA binding| |DNA-binding transcription factor activity| |mitotic cell cycle| |chromatin organization| |nucleolus| |negative regulation of transcription by RNA polymerase II| |peptidyl-amino acid modification| |cellular response to cytokine stimulus| |chromosome organization| |response to cytokine| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.76| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17655 * **Expression level (log2 read counts)**: 2.33 {{:chemogenomics:nalm6 dist.png?nolink |}}